'en:peripheral neuropathy'
(id=6855965 ; fe=en:peripheral neuropathy ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=20493 creation date=2017-06-25 touchdate=2025-12-20 00:35:11.000) ≈ 38 relations sortantes
- en:peripheral neuropathy --
r_has_conseq #41: 189 / 1 ->
en:paresis
n1=en:peripheral neuropathy | n2=en:paresis | rel=r_has_conseq | relid=41 | w=189
- en:peripheral neuropathy --
r_has_conseq #41: 185 / 0.979 ->
faiblesse du muscle
n1=en:peripheral neuropathy | n2=faiblesse du muscle | rel=r_has_conseq | relid=41 | w=185
- en:peripheral neuropathy --
r_has_conseq #41: 175 / 0.926 ->
parésie
n1=en:peripheral neuropathy | n2=parésie | rel=r_has_conseq | relid=41 | w=175
- en:peripheral neuropathy --
r_has_conseq #41: 168 / 0.889 ->
faiblesse musculaire
n1=en:peripheral neuropathy | n2=faiblesse musculaire | rel=r_has_conseq | relid=41 | w=168
- en:peripheral neuropathy --
r_has_conseq #41: 167 / 0.884 ->
parésie musculaire
n1=en:peripheral neuropathy | n2=parésie musculaire | rel=r_has_conseq | relid=41 | w=167
- en:peripheral neuropathy --
r_has_conseq #41: 163 / 0.862 ->
en:muscle weakness
n1=en:peripheral neuropathy | n2=en:muscle weakness | rel=r_has_conseq | relid=41 | w=163
- en:peripheral neuropathy --
r_has_conseq #41: 163 / 0.862 ->
faiblesse de muscle
n1=en:peripheral neuropathy | n2=faiblesse de muscle | rel=r_has_conseq | relid=41 | w=163
- en:peripheral neuropathy --
r_has_conseq #41: 155 / 0.82 ->
en:general paresis
n1=en:peripheral neuropathy | n2=en:general paresis | rel=r_has_conseq | relid=41 | w=155
- en:peripheral neuropathy --
r_has_conseq #41: 155 / 0.82 ->
paralysie générale
n1=en:peripheral neuropathy | n2=paralysie générale | rel=r_has_conseq | relid=41 | w=155
- en:peripheral neuropathy --
r_has_conseq #41: 137 / 0.725 ->
en:lower and upper limb muscle atrophy
n1=en:peripheral neuropathy | n2=en:lower and upper limb muscle atrophy | rel=r_has_conseq | relid=41 | w=137
- en:peripheral neuropathy --
r_has_conseq #41: 132 / 0.698 ->
en:distal limb muscle atrophy
n1=en:peripheral neuropathy | n2=en:distal limb muscle atrophy | rel=r_has_conseq | relid=41 | w=132
- en:peripheral neuropathy --
r_has_conseq #41: 131 / 0.693 ->
en:distal limb muscular weakness
n1=en:peripheral neuropathy | n2=en:distal limb muscular weakness | rel=r_has_conseq | relid=41 | w=131
- en:peripheral neuropathy --
r_has_conseq #41: 131 / 0.693 ->
en:distal muscular atrophy
n1=en:peripheral neuropathy | n2=en:distal muscular atrophy | rel=r_has_conseq | relid=41 | w=131
- en:peripheral neuropathy --
r_has_conseq #41: 130 / 0.688 ->
en:distal lower limb muscle atrophy
n1=en:peripheral neuropathy | n2=en:distal lower limb muscle atrophy | rel=r_has_conseq | relid=41 | w=130
- en:peripheral neuropathy --
r_has_conseq #41: 130 / 0.688 ->
en:lower limb muscle weakness
n1=en:peripheral neuropathy | n2=en:lower limb muscle weakness | rel=r_has_conseq | relid=41 | w=130
- en:peripheral neuropathy --
r_has_conseq #41: 129 / 0.683 ->
en:distal muscle weakness and atrophy of upper and lower limbs
n1=en:peripheral neuropathy | n2=en:distal muscle weakness and atrophy of upper and lower limbs | rel=r_has_conseq | relid=41 | w=129
- en:peripheral neuropathy --
r_has_conseq #41: 129 / 0.683 ->
en:distal muscle weakness and atrophy, predominantly lower limbs
n1=en:peripheral neuropathy | n2=en:distal muscle weakness and atrophy, predominantly lower limbs | rel=r_has_conseq | relid=41 | w=129
- en:peripheral neuropathy --
r_has_conseq #41: 129 / 0.683 ->
en:impaired gait
n1=en:peripheral neuropathy | n2=en:impaired gait | rel=r_has_conseq | relid=41 | w=129
- en:peripheral neuropathy --
r_has_conseq #41: 127 / 0.672 ->
en:distal muscle wasting
n1=en:peripheral neuropathy | n2=en:distal muscle wasting | rel=r_has_conseq | relid=41 | w=127
- en:peripheral neuropathy --
r_has_conseq #41: 127 / 0.672 ->
en:facial diplegia
n1=en:peripheral neuropathy | n2=en:facial diplegia | rel=r_has_conseq | relid=41 | w=127
- en:peripheral neuropathy --
r_has_conseq #41: 127 / 0.672 ->
en:peroneal muscle weakness and atrophy
n1=en:peripheral neuropathy | n2=en:peroneal muscle weakness and atrophy | rel=r_has_conseq | relid=41 | w=127
- en:peripheral neuropathy --
r_has_conseq #41: 126 / 0.667 ->
en:decreased corneal sensation
n1=en:peripheral neuropathy | n2=en:decreased corneal sensation | rel=r_has_conseq | relid=41 | w=126
- en:peripheral neuropathy --
r_has_conseq #41: 126 / 0.667 ->
en:knee and hip flexor weakness
n1=en:peripheral neuropathy | n2=en:knee and hip flexor weakness | rel=r_has_conseq | relid=41 | w=126
- en:peripheral neuropathy --
r_has_conseq #41: 125 / 0.661 ->
en:distal muscle atrophy
n1=en:peripheral neuropathy | n2=en:distal muscle atrophy | rel=r_has_conseq | relid=41 | w=125
- en:peripheral neuropathy --
r_has_conseq #41: 125 / 0.661 ->
en:lower and upper limb muscle weakness
n1=en:peripheral neuropathy | n2=en:lower and upper limb muscle weakness | rel=r_has_conseq | relid=41 | w=125
- en:peripheral neuropathy --
r_has_conseq #41: 125 / 0.661 ->
en:peroneal muscle weakness, transient, recurrent
n1=en:peripheral neuropathy | n2=en:peroneal muscle weakness, transient, recurrent | rel=r_has_conseq | relid=41 | w=125
- en:peripheral neuropathy --
r_has_conseq #41: 124 / 0.656 ->
en:distal limb muscular atrophy
n1=en:peripheral neuropathy | n2=en:distal limb muscular atrophy | rel=r_has_conseq | relid=41 | w=124
- en:peripheral neuropathy --
r_has_conseq #41: 124 / 0.656 ->
en:distal lower limb muscle weakness
n1=en:peripheral neuropathy | n2=en:distal lower limb muscle weakness | rel=r_has_conseq | relid=41 | w=124
- en:peripheral neuropathy --
r_has_conseq #41: 121 / 0.64 ->
en:distal limb muscle weakness
n1=en:peripheral neuropathy | n2=en:distal limb muscle weakness | rel=r_has_conseq | relid=41 | w=121
- en:peripheral neuropathy --
r_has_conseq #41: 121 / 0.64 ->
en:lower limb muscle atrophy
n1=en:peripheral neuropathy | n2=en:lower limb muscle atrophy | rel=r_has_conseq | relid=41 | w=121
- en:peripheral neuropathy --
r_has_conseq #41: 120 / 0.635 ->
en:syphilitic meningoencephalitis
n1=en:peripheral neuropathy | n2=en:syphilitic meningoencephalitis | rel=r_has_conseq | relid=41 | w=120
- en:peripheral neuropathy --
r_has_conseq #41: 119 / 0.63 ->
en:distal muscle weakness
n1=en:peripheral neuropathy | n2=en:distal muscle weakness | rel=r_has_conseq | relid=41 | w=119
- en:peripheral neuropathy --
r_has_conseq #41: 119 / 0.63 ->
en:muscular weakness
n1=en:peripheral neuropathy | n2=en:muscular weakness | rel=r_has_conseq | relid=41 | w=119
- en:peripheral neuropathy --
r_has_conseq #41: 25 / 0.132 ->
en:general paralysis
n1=en:peripheral neuropathy | n2=en:general paralysis | rel=r_has_conseq | relid=41 | w=25
- en:peripheral neuropathy --
r_has_conseq #41: 25 / 0.132 ->
en:paralytic dementia
n1=en:peripheral neuropathy | n2=en:paralytic dementia | rel=r_has_conseq | relid=41 | w=25
- en:peripheral neuropathy --
r_has_conseq #41: 16 / 0.085 ->
Paralysie générale
n1=en:peripheral neuropathy | n2=Paralysie générale | rel=r_has_conseq | relid=41 | w=16
- en:peripheral neuropathy --
r_has_conseq #41: 4 / 0.021 ->
diplégie faciale
n1=en:peripheral neuropathy | n2=diplégie faciale | rel=r_has_conseq | relid=41 | w=4
- en:peripheral neuropathy --
r_has_conseq #41: 2 / 0.011 ->
en:enfeeblement of muscle
n1=en:peripheral neuropathy | n2=en:enfeeblement of muscle | rel=r_has_conseq | relid=41 | w=2
| ≈ 23 relations entrantes
- cis-diaminedichloroplatine ---
r_has_conseq #41: 61 -->
en:peripheral neuropathy
n1=cis-diaminedichloroplatine | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=61
- cisplatine ---
r_has_conseq #41: 60 -->
en:peripheral neuropathy
n1=cisplatine | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=60
- en:cisplatin ---
r_has_conseq #41: 60 -->
en:peripheral neuropathy
n1=en:cisplatin | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=60
- bortézomib ---
r_has_conseq #41: 47 -->
en:peripheral neuropathy
n1=bortézomib | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=47
- en:inflammation ---
r_has_conseq #41: 38 -->
en:peripheral neuropathy
n1=en:inflammation | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=38
- en:metabolic disorder ---
r_has_conseq #41: 38 -->
en:peripheral neuropathy
n1=en:metabolic disorder | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=38
- maladie métabolique ---
r_has_conseq #41: 36 -->
en:peripheral neuropathy
n1=maladie métabolique | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=36
- en:type 1 diabetes mellitus ---
r_has_conseq #41: 35 -->
en:peripheral neuropathy
n1=en:type 1 diabetes mellitus | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=35
- oxaliplatine ---
r_has_conseq #41: 35 -->
en:peripheral neuropathy
n1=oxaliplatine | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=35
- CDDP ---
r_has_conseq #41: 28 -->
en:peripheral neuropathy
n1=CDDP | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=28
- en:cisplatinum ---
r_has_conseq #41: 22 -->
en:peripheral neuropathy
n1=en:cisplatinum | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=22
- en:oxaliplatin ---
r_has_conseq #41: 22 -->
en:peripheral neuropathy
n1=en:oxaliplatin | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=22
- trouble métabolique ---
r_has_conseq #41: 21 -->
en:peripheral neuropathy
n1=trouble métabolique | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=21
- Bortézomib ---
r_has_conseq #41: 20 -->
en:peripheral neuropathy
n1=Bortézomib | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=20
- Borst-Jadassohn (épithélioma intra-épidermique de) ---
r_has_conseq #41: 15 -->
en:peripheral neuropathy
n1=Borst-Jadassohn (épithélioma intra-épidermique de) | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=15
- Maladie métabolique ---
r_has_conseq #41: 15 -->
en:peripheral neuropathy
n1=Maladie métabolique | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=15
- ciseaux (marche en) ---
r_has_conseq #41: 15 -->
en:peripheral neuropathy
n1=ciseaux (marche en) | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=15
- en:metabolic disturbance ---
r_has_conseq #41: 15 -->
en:peripheral neuropathy
n1=en:metabolic disturbance | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=15
- Cisplatine ---
r_has_conseq #41: 10 -->
en:peripheral neuropathy
n1=Cisplatine | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=10
- Oxaliplatine ---
r_has_conseq #41: 10 -->
en:peripheral neuropathy
n1=Oxaliplatine | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=10
- en:Borst-Jadassohn's intraepidermal epithelioma ---
r_has_conseq #41: 10 -->
en:peripheral neuropathy
n1=en:Borst-Jadassohn's intraepidermal epithelioma | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=10
- en:scissors gait ---
r_has_conseq #41: 10 -->
en:peripheral neuropathy
n1=en:scissors gait | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=10
- bortésomib ---
r_has_conseq #41: 5 -->
en:peripheral neuropathy
n1=bortésomib | n2=en:peripheral neuropathy | rel=r_has_conseq | relid=41 | w=5
|